Medindia
Medindia LOGIN REGISTER
Advertisement

Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio

Tuesday, August 17, 2010 Corporate News
Advertisement
CLEVELAND, Ohio, August 16, 2010 Simbionix USACorporation, the world's leading provider of medical education and simulationtraining products for medical professionals and the healthcare industry, willconsolidate its eTrinsic custom courseware business currently located inDenver, Colorado and relocate those operations to its Corporate Headquartersin Cleveland, Ohio under its expanding Medical Education Division (MED).
Advertisement

The move will enable Simbionix to better focus on its strategicdirection, enhance its mobile and web-based medical education products andservices, and improve reaction to customer and market needs. "This is a veryexciting time for Simbionix", stated Paul Jensen, the GM of the new andexpanding Medical Education Division, "we are developing a number ofinnovative products. Having everyone in one location will facilitatecollaboration across the team and improve our ability to rapidly deliverhigh-quality solutions."
Advertisement

The company recently announced the expansion of its CorporateHeadquarters. The move will be completed by the end of September 2010.

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and trainingproducts for medical professionals and the healthcare industry. Founded in1997, the company is committed to delivering high quality products, advancingclinical performance and optimizing procedural outcomes.For more information on Simbionix, visit http://www.simbionix.com Contact: Rebecca Zitter Manager of Marketing Communications and Distributor Relations [email protected] +1-216-229-2040

SOURCE Simbionix Ltd.
Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close